Anti-TNF alpha therapy does not always protect rheumatoid arthritis patients against developing pericarditis [3]

Clinical and Experimental Rheumatology

Volumn 25, Issue 4, 2007, Pages 660-

  Ambrose, N L ^a   O'Connell, P G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; CASE REPORT; DIALYSIS; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; FEMALE; HEART PROTECTION; HUMAN; LETTER; MULTIPLE CYCLE TREATMENT; PERICARDIOCENTESIS; PERICARDITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

AGED; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MIDDLE AGED; PERICARDITIS, CONSTRICTIVE;

EID: 34648813470     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. VOSKUYL AE: The heart and cardiovascular manifestations in rheumatoid arthritis. Rheum (Oxford) 2006; 45 (Suppl. 4): Iv 4-iv7.
2. SILMAN AJ, DAVIES P, CURREY HLF, EVANS SJW: Is rheumatoid arthritis becoming less severe? J Chronic Dis 1983; 36: 891-7.
3. DORAN MF, POND GR, CROWSON CS, O'FALLON WM, GABRIEL SE: Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty year period. Arthritis Rheum 2002: 46: 625-31
4. GABRIEL SE, CROWSON CS, O'FALLON WM: Mortality in rheumatoid arthritis: Have we made an impact in 4 decades? J Rheumatol 1999; 26: 2529-33.
5. MCRORIE ER, ERRINGTON ML, LUQMANI RA: Rheumatoid constrictive pericarditis. Br J Rheumatol 1997; 36: 100-3.
6. EDREES AF, MISRA SM, ABDOU NI: Anti tumor necrosis factor therapy in rheumatoid arthritis: Correlation of TNF-alpha serum level with clinical response and benefit from changing dose or frequency of infliximab infusions. Clin Exp Rheumatol 2005: 23: 469-74.